Arkolith/Insider Trading/AGIO/Form 4

Washburn Theodore James Jr.

Principal Accounting OfficerAGIOS PHARMACEUTICALS, INC. (AGIO) · full profile →Form 4 · filed Mar 3, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$64K
Net Open-Market Flow
-$64K
Transactions
10
6 non-derivative · 4 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Mar 2, 2026Sell(S)698$28.96$20K3K
Mar 2, 2026Sell(S)727$28.96$21K4K
Mar 2, 2026Option exercise(M)3K—$07K
Mar 2, 2026Sell(S)798$28.96$23K6K
Mar 2, 2026Option exercise(M)2K—$05K
Mar 2, 2026Option exercise(M)2K—$03K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Mar 2, 2026Option exercise(M)2K—$02K
Mar 2, 2026Option exercise(M)3K—$05K
Mar 2, 2026Option exercise(M)2K—$00
Mar 1, 2026Grant(A)8K—$08K

Transaction Codes

S
Open-market sale
M
Option exercise / conversion
A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001439222-26-000034) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML